Overview This page contains the latest trade data of Antisera and other blood fractions. In 2022, Antisera and other blood fractions were the world's 87th most traded product, with a total trade of $37.2B. Between 2021 and 2022 the exports of Antisera and other blood fractions grew by 16.1%, from $32B to $37.2B. Trade in Antisera and other blood fractions represent 0.16% of total world trade.
Antisera and other blood fractions are a part of Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other....
Exports In 2022 the top exporters of Antisera and other blood fractions were United States ($10.3B), Germany ($8.2B), Switzerland ($3.87B), Austria ($3.36B), and Spain ($1.34B).
Imports In 2022 the top importers of Antisera and other blood fractions were Germany ($6.45B), United States ($6.14B), Switzerland ($3.66B), Austria ($3.09B), and China ($1.99B).
Ranking Antisera and other blood fractions ranks 1061st in the Product Complexity Index (PCI).